Our data indicated that AD-like phenotype could modify the hepatic VA metabolism, as shown by increased hepatic VA level and significantly decreased hepatic RBP4 level in APP/PS1 control mice than C57 control mice. The gene discussed is APP; the disease is Alzheimer disease.